ROR1
Inactive tyrosine-protein kinase transmembrane receptor ROR1
Also known as: NTRKR1, ROR1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q01973
- Gene
- ROR1
- Ensembl
- ENSG00000185483
- Chromosome
- 1
- Canonical length
- 937 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a receptor tyrosine kinase-like orphan receptor that modulates neurite growth in the central nervous system. The encoded protein is a glycosylated type I membrane protein that belongs to the ROR subfamily of cell surface receptors. It is a pseudokinase that lacks catalytic activity and may interact with the non-canonical Wnt signalling pathway. This gene is highly expressed during early embryonic development but expressed at very low levels in adult tissues. Increased expression of this gene is associated with B-cell chronic lymphocytic leukaemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jun 2012]
Canonical amino-acid sequenceUniProt
937 residues, UniProt reviewed canonical sequence.
>Q01973|ROR1
1 MHRPRRRGTR PPLLALLAAL LLAARGAAAQ ETELSVSAEL VPTSSWNISS ELNKDSYLTL
61 DEPMNNITTS LGQTAELHCK VSGNPPPTIR WFKNDAPVVQ EPRRLSFRST IYGSRLRIRN
121 LDTTDTGYFQ CVATNGKEVV SSTGVLFVKF GPPPTASPGY SDEYEEDGFC QPYRGIACAR
181 FIGNRTVYME SLHMQGEIEN QITAAFTMIG TSSHLSDKCS QFAIPSLCHY AFPYCDETSS
241 VPKPRDLCRD ECEILENVLC QTEYIFARSN PMILMRLKLP NCEDLPQPES PEAANCIRIG
301 IPMADPINKN HKCYNSTGVD YRGTVSVTKS GRQCQPWNSQ YPHTHTFTAL RFPELNGGHS
361 YCRNPGNQKE APWCFTLDEN FKSDLCDIPA CDSKDSKEKN KMEILYILVP SVAIPLAIAL
421 LFFFICVCRN NQKSSSAPVQ RQPKHVRGQN VEMSMLNAYK PKSKAKELPL SAVRFMEELG
481 ECAFGKIYKG HLYLPGMDHA QLVAIKTLKD YNNPQQWTEF QQEASLMAEL HHPNIVCLLG
541 AVTQEQPVCM LFEYINQGDL HEFLIMRSPH SDVGCSSDED GTVKSSLDHG DFLHIAIQIA
601 AGMEYLSSHF FVHKDLAARN ILIGEQLHVK ISDLGLSREI YSADYYRVQS KSLLPIRWMP
661 PEAIMYGKFS SDSDIWSFGV VLWEIFSFGL QPYYGFSNQE VIEMVRKRQL LPCSEDCPPR
721 MYSLMTECWN EIPSRRPRFK DIHVRLRSWE GLSSHTSSTT PSGGNATTQT TSLSASPVSN
781 LSNPRYPNYM FPSQGITPQG QIAGFIGPPI PQNQRFIPIN GYPIPPGYAA FPAAHYQPTG
841 PPRVIQHCPP PKSRSPSSAS GSTSTGHVTS LPSSGSNQEA NIPLLPHMSI PNHPGGMGIT
901 VFGNKSQKPY KIDSKQASLL GDANIHGHTE SMISAELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ROR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 23 nTPM
- blood vessel: 10 nTPM
- smooth muscle: 6.5 nTPM
- cervix: 6.4 nTPM
- heart muscle: 6.4 nTPM
- endometrium: 6.1 nTPM
Single-cell type
- alveolar cells type 1: 1,247 nCPM
- cardiomyocytes: 921 nCPM
- choroid plexus epithelial cells: 778 nCPM
- mucous neck cells: 631 nCPM
- epicardial cells: 591 nCPM
- mesothelial cells: 564 nCPM
Immune cell
- NK-cell: 0.8 nTPM
- plasmacytoid DC: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- choroid plexus: 13 nTPM
- cerebellum: 8.8 nTPM
- basal ganglia: 5.4 nTPM
- thalamus: 5.1 nTPM
- white matter: 4.7 nTPM
- midbrain: 4.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ROR1.
Disease | AllUniProt
Conditions ROR1 is implicated in, by any mechanism.
- Deafness, autosomal recessive, 108 (DFNB108) MIM:617654
Disease | ImmuneIEDB
Conditions an epitope on ROR1 was assayed in.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.27
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.17
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- astrocyte development
- cell population proliferation
- cell surface receptor protein tyrosine kinase signaling pathway
- inner ear development
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of NF-kappaB transcription factor activity
- sensory perception of sound
Molecular functions
- ATP binding
- coreceptor activity
- signaling receptor activity
- transmembrane receptor protein tyrosine kinase activity
- Wnt receptor activity
- Wnt-protein binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Kringle
- Protein kinase domain
- Serine-threonine/tyrosine-protein kinase, catalytic domain
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Immunoglobulin-like domain
- Tyrosine-protein kinase, active site
- Protein kinase-like domain superfamily
- Immunoglobulin I-set
- Immunoglobulin-like fold
- Kringle-like fold
- Tyrosine-protein kinase, receptor ROR
- Kringle, conserved site
- Frizzled domain
- Immunoglobulin-like domain superfamily
- Frizzled cysteine-rich domain superfamily
- Kringle superfamily
- Receptor Tyrosine Kinase
- Kringle domain
- Fz domain
- Immunoglobulin I-set domain
- Protein tyrosine and serine/threonine kinase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ROR1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ROR1 as an antibody target. Whether an autoantibody or antibody against ROR1 could matter depends on whether native ROR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ROR1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ROR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...